The Justice Department has granted antitrust approval for CVS Health's bid to acquire insurer Aetna in a $69 billion deal that could change health care access for many Americans. The approval stipulates that CVS must first sell Aetna's Medicare Part D prescription drug plan business.
Sign up for CPA Letter Daily
The latest CPA news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.